EMA — authorised 12 July 2013
- Marketing authorisation holder: Roche Registration Ltd
- Status: approved
EMA authorised Erivedge on 12 July 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 12 July 2013.
Roche Registration Ltd holds the EU marketing authorisation.